SEC Form 4 · accession 0001127602-16-046103

THERMO FISHER SCIENTIFIC INC. · TMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Mar 9, 2016

Accepted (ET)

Mar 11, 2016 · 4:07 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000097745

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 9, 2016	M	11,525	$73.24	A	62,732	D
Common Stock^F2	Mar 9, 2016	S	8,600	$137.83	D	54,132	D
Common Stock^F3	Mar 9, 2016	S	4,446	$139.66	D	49,686	D
Common Stock^F4	Mar 9, 2016	S	2,400	$138.76	D	47,286	D
Common Stock	holding	—	—		—	14,256	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F5	$73.24	Mar 9, 2016	M	11,525	D	—	Feb 26, 2020	Common Stock	11,525	11,525	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2016.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.50 to $138.48, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.50 to $140.13, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.50 to $139.35, inclusive.
F5The option vests in four equal annual installments beginning on February 26, 2014.